Skip to main content

Pharma News

Crack GPAT — Prepare for GPAT Online 

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Antidepressants may act in gut to reduce depression and anxiety

    Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue.

  • A new class of antivirals could help prevent future pandemics
    The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic—an effective antiviral that has since successfully treated millions. But like many antivirals before it, scientists know that at some point, Paxlovid is likely to lose some efficacy due to drug resistance. Researchers working to stay ahead of such emerging threats have now identified a wholly new way to treat SARS-CoV-2 infections—work that may have even broader implications.
  • Cipla receives approval for distribution and marketing of inhaled insulin in India
    Cipla Limited announced that it has obtained regulatory approval from Central Drugs Standard Control Organisation for the exclusive distribution and marketing of Afrezza insulin human Inhalation Powder in India. Afrezza, a product created and manufactured by MannKind Corporation
  • Identifying a proliferating repairman for tissue in damaged lungs

    Veins in the lungs, or pulmonary veins, play a critical role not only in lung functioning but also in maintaining sufficient oxygen in tissue throughout the body. When a person sustains pulmonary injury from an illness like influenza or COVID, repair of blood vessels and the creation of new ones is vital to meet oxygen demands; however, research in these areas remains underexplored.

  • Updated Hep B Vaccine More Effective for People with HIV

    A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to the results of an international study led by a Weill Cornell Medicine investigator.

  • Stanford scientists transform ubiquitous skin bacterium into a topical vaccine

    Imagine a world in which a vaccine is a cream you rub onto your skin instead of a needle a health care worker pushes into your one of your muscles. Even better, it’s entirely pain-free and not followed by fever, swelling, redness or a sore arm. No standing in a long line to get it. Plus, it’s cheap.

  • Academically Announces Outstanding KAPS 2024 Results and OPRA Exam Transition

    Academically, a pioneering healthcare EdTech company, proudly shares the exciting news of its students' exceptional performance in the final KAPS (Knowledge Assessment of Pharmaceutical Sciences) exam before transitioning to the OPRA (Overseas Pharmacists Readiness Assessment). Held on 25th November 2024, this final edition of the exam saw Academically students achieving a remarkable success rate of 90.51%.

  • Cancer fingerprint can improve early detection

    Different types of cancer have unique molecular ‘fingerprints’ which are detectable in early stages of the disease and can be picked up with near-perfect accuracy by small, portable scanners in just a few hours, according to a study published today in the journal Molecular Cell.

  • NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

    The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox and a low risk of developing severe disease, according to an interim data analysis from the international clinical trial called the Study of Tecovirimat for Mpox (STOMP). There were no safety concerns associated with tecovirimat.

  • PAHO highlights increase in dengue, Oropouche, and avian influenza cases in the Americas
    The Pan American Health Organization reported on three transmissible diseases affecting the Region of the Americas: dengue, Oropouche, and avian influenza. PAHO Director Dr. Jarbas Barbosa expressed concern over the increase in cases in 2024 but emphasized effective strategies to control the outbreaks and mitigate their impact.
Subscribe to Pharma News